XJPX4183
Market cap4.10bUSD
Dec 24, Last price
3,386.00JPY
1D
0.83%
1Q
-13.64%
Jan 2017
28.99%
Name
Mitsui Chemicals Inc
Chart & Performance
Profile
Mitsui Chemicals, Inc. engages in the mobility, health care, food and packaging, basic materials, and other businesses. The company's Mobility segment develops elastomers, performance compounds, functional polymers, polypropylene compounds, and performance polymers; and offers services related to the development of automotive and industrial products. Its Health Care segment offers vision care materials, nonwoven fabrics, dental materials, and personal care materials. The Food & Packaging segment provides coating and engineering materials, performance films and sheets, and agrochemical products. The Basic Materials segment provides ethylene, propylene, polyethylene, polypropylene, catalysts, phenols, purified terephthalic acid, PET, polyurethane materials, and industrial chemical products. The company also offers civil engineering and construction materials; cosmetics; wood adhesives, paper resins, foliar activator, and other chemical products; polyolefin, urethanes, and synthetic resins and resin films; injection molds and presses; phosphoric acid and fertilizers; spunbonded nonwoven fabrics and synthetic fibers; monomers for optical lenses; and fine chemical products and inorganic chemicals. In addition, it is involved in performance analysis, physical property measurements, and safety tests on chemicals; and placements, temporary works, and insurance and travel services, and consignments, as well as the sale of electronics and information materials. The company sells its products in Japan, China, Asia, the Americas, Europe, and internationally. Mitsui Chemicals, Inc. was founded in 1892 and is headquartered in Tokyo, Japan.
IPO date
Oct 05, 1962
Employees
18,933
Domiciled in
JP
Incorporated in
JP
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 1,749,743,000 -6.91% | 1,879,547,000 16.55% | 1,612,688,000 33.09% | |||||||
Cost of revenue | 1,664,372,000 | 1,902,985,000 | 1,580,048,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 85,371,000 | (23,438,000) | 32,640,000 | |||||||
NOPBT Margin | 4.88% | 2.02% | ||||||||
Operating Taxes | 19,556,000 | 27,140,000 | 22,723,000 | |||||||
Tax Rate | 22.91% | 69.62% | ||||||||
NOPAT | 65,815,000 | (50,578,000) | 9,917,000 | |||||||
Net income | 49,999,000 -39.71% | 82,936,000 -24.60% | 109,990,000 90.05% | |||||||
Dividends | (24,714,000) | (24,161,000) | (20,527,000) | |||||||
Dividend yield | 3.00% | 3.68% | 3.42% | |||||||
Proceeds from repurchase of equity | (46,000) | (10,018,000) | (10,031,000) | |||||||
BB yield | 0.01% | 1.53% | 1.67% | |||||||
Debt | ||||||||||
Debt current | 333,597,000 | 368,463,000 | 346,615,000 | |||||||
Long-term debt | 477,860,000 | 417,794,000 | 359,212,000 | |||||||
Deferred revenue | 83,517,000 | 73,205,000 | ||||||||
Other long-term liabilities | 79,628,000 | 991,000 | 465,000 | |||||||
Net debt | 361,905,000 | 228,253,000 | 205,144,000 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 161,339,000 | 101,241,000 | 92,584,000 | |||||||
CAPEX | (144,068,000) | (137,861,000) | (116,216,000) | |||||||
Cash from investing activities | (123,939,000) | (106,340,000) | (205,234,000) | |||||||
Cash from financing activities | (26,016,000) | 2,542,000 | 89,222,000 | |||||||
FCF | (82,153,000) | (153,624,000) | (175,725,000) | |||||||
Balance | ||||||||||
Cash | 210,292,000 | 262,719,000 | 224,648,000 | |||||||
Long term investments | 239,260,000 | 295,285,000 | 276,035,000 | |||||||
Excess cash | 362,064,850 | 464,026,650 | 420,048,600 | |||||||
Stockholders' equity | 962,530,000 | 1,584,000,000 | 1,448,634,000 | |||||||
Invested Capital | 1,468,636,150 | 1,234,617,350 | 1,113,926,400 | |||||||
ROIC | 4.87% | 1.00% | ||||||||
ROCE | 4.56% | 2.09% | ||||||||
EV | ||||||||||
Common stock shares outstanding | 190,121 | 192,350 | 194,517 | |||||||
Price | 4,331.00 27.01% | 3,410.00 10.36% | 3,090.00 -11.59% | |||||||
Market cap | 823,412,241 25.54% | 655,912,518 9.13% | 601,056,130 -11.44% | |||||||
EV | 1,307,272,241 | 1,706,412,518 | 1,577,114,130 | |||||||
EBITDA | 180,620,000 | 68,642,000 | 116,862,000 | |||||||
EV/EBITDA | 7.24 | 24.86 | 13.50 | |||||||
Interest | 14,663,000 | 17,398,000 | 12,211,000 | |||||||
Interest/NOPBT | 17.18% | 37.41% |